What is the share price of Dr Lal Pathlab?
The share price of Dr. Lal PathLabs Limited (traded on the National Stock Exchange of India under the ticker LALPATHLAB) is approximately 1,904.90 INR. Dr. Lal PathLabs is a leading diagnostic and pathology laboratory network operating a vast collection center infrastructure across India. Its market valuation is shaped by rising healthcare awareness, preventive health screening adoption, expansion of insurance penetration, competitive pressures in retail diagnostics, network volume growth, and quarterly financial earnings performance.
Related FAQs
Melania Trump's linguistic capabilities have been a frequent subject of public interest and biographical discussion.
Sumitomo tires are frequently categorized as a mid-tier value brand, offering prices that are often significantly lower—sometimes around 30%—than major competitors like Cooper, Hankook, or Kumho [1.2.1].
DTE Energy Company has a corporate history that includes historical stock splits and structural share adjustments executed during earlier decades as a regulated utility provider.
Elis operates in 30 countries across Europe and Latin America, employing over 54,000 people locally to deliver specialized circular services at work.
Dr. Lal PathLabs is widely recognized as a major provider of diagnostic and laboratory services, particularly within India, and is generally regarded for its commitment to precise testing and professional diagnostic standards.
Dr. Lal PathLabs anticipates a favorable future growth outlook supported by rising healthcare awareness, expanding diagnostic testing networks, and increasing demand for preventive health packages across India.
Dr. Lal PathLabs Limited commands a robust market capitalization valuation fluctuating around ₹750 billion (approximately $9 billion USD).
Dr. Lal PathLabs distributes regular interim and final cash dividend payments to its eligible shareholders, operating as a prominent publicly traded diagnostic healthcare enterprise listed on Indian stock exchanges.
Dr. Lal PathLabs, one of India's leading diagnostic and laboratory testing service providers, operates numerous collection centers, regional laboratories, and its prominent reference testing facilities across Delhi.
Bessemer Trust is a privately held wealth management and investment advisory firm, and therefore it does not have a publicly reported market capitalization like a publicly traded company.
Dr. Lal PathLabs Limited has established a strong corporate track record of rewarding its equity shareholders through capital capitalization and bonus share issuances, highlighted by a significant 1:1 bonus issue.
Yes, Dr. Lal PathLabs operates using a business model that includes franchise opportunities for individuals interested in the healthcare diagnostic sector.
Yes, you can receive a refund if you cancel your policy within the designated "free-look period," which is typically 15 days, allowing for approximately 100% of the paid premium to be refunded, minus any costs for pre-policy health check-ups.
The full official corporate name of the prominent Indian healthcare diagnostics enterprise is Dr. Lal PathLabs Limited. Founded by Dr. S.K. Lal, the company has evolved into a leading national provider of diagnostic and laboratory testing services.
As of mid-2026, Dr. Lal PathLabs Ltd has reported a dividend yield of approximately 1.34%. This yield is based on the company's recent dividend payments, including a dividend of ₹5.00 per share announced in July 2026.
Lamar Bank and Trust provides fully featured mobile banking applications and digital portals enabling customers to access their accounts conveniently from anywhere at any time.
Landstar System Inc. (LSTR) navigates a cyclical freight and transportation market environment, with recent financial disclosures reflecting soft spot market pricing and lower revenue per load consistent with broader industry trends.
Dr. Lal PathLabs Limited implements a structured and rewarding dividend distribution schedule, reflecting its strong financial performance and leading market share within the Indian diagnostic and healthcare services sector.
Dr Lal PathLabs operates a diagnostic and healthcare services business model centered on providing comprehensive laboratory testing, pathology services, and clinical radiology solutions.
The share price of Dr. Lal PathLabs Limited (traded on the National Stock Exchange of India under the ticker LALPATHLAB) is approximately 1,904.90 INR. Dr.